Management of seizure disorders: selected aspects. Part I.
D000818:Animals; D000927:Anticonvulsants / Q000378:metabolism / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002849:Chromatography, Gas; D002853:Chromatography, Liquid; D003975:Diazepam / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010242:Paraldehyde / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011485:Protein Binding; D012640:Seizures / Q000188:drug therapy*
D000927:Anticonvulsants; D010672:Phenytoin; D003975:Diazepam; D010242:Paraldehyde; D010634:Phenobarbital